[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 59, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 62, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 57, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 68, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Luis  Sanay C.F.A.", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 54, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 62, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.78, "open": 7.77, "dayLow": 7.732, "dayHigh": 8.33, "regularMarketPreviousClose": 7.78, "regularMarketOpen": 7.77, "regularMarketDayLow": 7.732, "regularMarketDayHigh": 8.33, "payoutRatio": 0.0, "beta": 2.371, "trailingPE": 3.9850748, "forwardPE": -22.068548, "volume": 5403394, "regularMarketVolume": 5403394, "averageVolume": 3919511, "averageVolume10days": 5120280, "averageDailyVolume10Day": 5120280, "bid": 7.97, "ask": 8.04, "bidSize": 3, "askSize": 3, "marketCap": 1301617024, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 10.64, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.2225763, "fiftyDayAverage": 7.0144, "twoHundredDayAverage": 7.34775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 789862976, "profitMargins": 0.32099, "floatShares": 133709048, "sharesOutstanding": 162498995, "sharesShort": 54721714, "sharesShortPriorMonth": 51861435, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.3368, "heldPercentInsiders": 0.087510005, "heldPercentInstitutions": 0.62387, "shortRatio": 17.27, "shortPercentOfFloat": 0.338, "impliedSharesOutstanding": 162498995, "bookValue": -0.964, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 341744992, "trailingEps": 2.01, "forwardEps": -0.36296, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.742, "enterpriseToEbitda": 1.748, "52WeekChange": -0.09080589, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 8.01, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.77778, "targetMedianPrice": 11.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 762894016, "totalCashPerShare": 4.695, "ebitda": 451828000, "totalDebt": 251140000, "quickRatio": 1.854, "currentRatio": 2.267, "totalRevenue": 1064651008, "revenuePerShare": 6.595, "returnOnAssets": 0.18014, "grossProfits": 632619008, "freeCashflow": -455231136, "operatingCashflow": -378323008, "revenueGrowth": -0.166, "grossMargins": 0.59419996, "ebitdaMargins": 0.42439, "operatingMargins": -1.12684, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "corporateActions": [], "postMarketTime": 1768611011, "regularMarketTime": 1768597201, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.9563, "regularMarketPrice": 8.01, "postMarketChangePercent": 0.0, "postMarketPrice": 8.01, "postMarketChange": 0.0, "regularMarketChange": 0.23, "regularMarketDayRange": "7.732 - 8.33", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3919511, "fiftyTwoWeekLowChange": 3.0, "fiftyTwoWeekLowChangePercent": 0.5988024, "fiftyTwoWeekRange": "5.01 - 10.64", "fiftyTwoWeekHighChange": -2.63, "fiftyTwoWeekHighChangePercent": -0.24718045, "fiftyTwoWeekChangePercent": -9.080589, "dividendDate": 1557446400, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.01, "epsForward": -0.36296, "epsCurrentYear": 2.03522, "priceEpsCurrentYear": 3.9356928, "fiftyDayAverageChange": 0.9956002, "fiftyDayAverageChangePercent": 0.14193662, "twoHundredDayAverageChange": 0.66225004, "twoHundredDayAverageChangePercent": 0.090129636, "priceToBook": -8.309129, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]